Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

By P. Das, Adeeba Kamarulzaman, T. Mok, J. O'Grady. 2011

839 citations recorded by the source corpus.